Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Greenwich LifeSciences, Inc. (GLSI) had Cash Flow from Financial Activities of $12.00M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-7.92M |
|
-- |
|
-- |
|
$7.95M |
|
$-7.95M |
|
$0.02M |
|
$-7.92M |
|
$-7.92M |
|
$-7.92M |
|
$-7.92M |
|
$-7.92M |
|
$-7.92M |
|
$-7.95M |
|
$-7.95M |
|
13.54M |
|
13.54M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$6.18M |
|
-- |
|
-- |
|
$6.18M |
|
$5.82M |
|
-- |
|
-- |
|
$5.82M |
|
$0.35M |
|
$0.35M |
|
$0.35M |
|
14.30M |
|
| Cash Flow Statement Financials | |
$-9.91M |
|
-- |
|
|
Cash Flow from Financial Activities |
$12.00M |
$4.09M |
|
$6.18M |
|
$2.09M |
|
$6.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2243.06% |
|
-2243.02% |
|
-128.24% |
|
-2243.02% |
|
$0.02 |
|
$-0.73 |
|
$-0.73 |
|